BW/CW PROTECTION

File: 120596_aacet_01.txt
Page: 01
Total Pages: 1

PAASZYU~ RHIUFAA2877 D16~347- -~RNIUFNA.

ZNY.

151300Z JAN 91

FM USCENTAF//SG//
TO AIG 8598//CC/SG/DOS//

RNIEFAA/1TAC ASF7/CC/SG/DOS//

RUHGPEM/5TAC ASF//CC/SG/OOS//

RHIUFGA/237AC ASF//CC/SC/DOS//

RUDOHAA/22TAC ASF//CC/SG/DOS//

RHIDFGA/4OlTFW DEPLOYED//CC/SC/DOS//
SUBJECT: BW/CW PROTECTION
USCENTAF/SG #91-JAN-066

1. CIPROFLOXACIN, FOR USE AS PROPHYLACTIC ANTIBIOTIC
AGAINST BIOLOGICAL WARFARE AGENTS, WILL PE DISTRIBUTED TQ MEDICAL
FACILITIES SOON. THE BLISTER STRIPS SHOULD BE ISSUED TO THE
INDIVIDUAL SERVICE MEMBER IN STRIPS OF TEN EACH. EACH INDIVIDUAL
SHOULD BE TOLD THAT THEY WILL START TAKING THE TABLETS WHEN
INSTRUCTED TO DO SO AT A RATE OF ONE TABLET EVERY 12 HOURS. BULK
CIPROFLOXACIN FOR TREATMENT WILL ALSO BE DISTRIBUTED TO MEDICAL
FACILITIES. THIS WILL BE USED TO FOLLOW THE INITIAL 5 DAY SUPPLY

PAGE 2 RHIUFAA2877

PROVIDED IN BLISTER PACKS. IF PERSONNEL ARE EXPOSED TO
BIOLOGICAL WARFARE AGENTS THEY SHOULD CONTINUE TO RECEIVE THE
ANTIBIOTIC FOR 30 DAYS. IF IT IS SUSPECTED THAT THE EXPOSURE WAS
ANTHRAX, AN INITIAL VACCINATION OR A BOOSTER SHOULD ALSO BE
ADMINISTERED BEFORE SYMPTOMS DEVELOP.
2. THE FIRST 25,000 CONVULSANT ANTIDOTE FOR NERVE ACENT
(CANA) HAVE BEEN RECEIVED AND ADDITIONAL QUANTITIES ARE EXPECTED. DISASTER PREPAREDNESS IS RESPONSIBLE FOR PROVIDING INSTRUCTION ON THE USE OF CANA.
3. CANA WILL DE DISTRIBUTED FROM HIGH RISK TO LOW RISK
AREAS AS THEY BECOME AVAILABLE. CANA IS TO BE STORED IN THE
MEDICAL FACILITY AND ISSUED WHEN THE THREAT WARRENTS SUCH ACTION.
THE WING COMMANDER, WITH INPUT FROM SG AND IN, WILL DIRECT WHEN
TO ISSUE CANA AND WHEN TO START TAKING CIPROFLOXACIN. THE SG
SHOULD USE UNIT DISASTER PREPAREDNESS OFFICERS TO MAKE
DISTRIBUTION LOCALLY. A RECORD OF INDIVIDUAL ISSUE MUST BE KEPT FOR CANA. THE INJECTORS WILL BE RETURNED TO THE MEDICAL FACILITY WHEN THE THREAT SUBSIDES.
4, [(b)(2)]
FACE 3 RHIUFAA2877
MINIMIZE CONSIDERED